Diabetes quietly reshapes what Medicare is willing to pay for. A disease that damages the nerves and the circulation in the feet turns items a healthy retiree would grab off a rack at any shoe store into covered medical equipment, and it opens the door to regular podiatry that the program otherwise treats as mere grooming. Part B covers therapeutic shoes, custom inserts, and periodic foot exams for beneficiaries whose diabetes has reached the nerves in their legs and feet. The coverage is aimed squarely at heading off the ulcers and amputations that a single missed sore or an ill-fitting shoe can set in motion.
How diabetes changes the coverage rules
Part B covers a foot exam every six months for beneficiaries with diabetes-related nerve damage and a documented loss of protective sensation, as long as they have not seen a foot specialist for some other reason in between. That last clause is deliberate rather than bureaucratic: the exam is a scheduled preventive check on numb feet that can hide a blister or a puncture until it has already turned dangerous. Medicare will also cover more frequent visits for patients who have already lost part of a foot to a non-traumatic amputation or who show early signs of serious foot disease.
The program still draws a hard line around ordinary maintenance. Cutting corns and calluses, trimming toenails, and general hygienic care all stay uncovered for a healthy foot, treated as personal grooming the beneficiary is expected to handle. It is the presence of diabetes-related neuropathy that converts that identical care into a medically necessary service, because a small cut on an insensate foot carries a risk of infection and limb loss that an ordinary patient with full sensation would never have to weigh.
That same preventive reasoning runs straight through Medicare’s other diabetes benefits, from covered blood-sugar monitors and test strips to diabetes self-management training that teaches patients how to inspect their own feet and spot trouble early. Each individual piece is cheap relative to the complication it is meant to prevent, and taken together they form a coverage package deliberately built around a single very expensive risk rather than around a patient’s day-to-day comfort.
Free retirement updates: Want plain-English help keeping more of your money in retirement? The free Retirement Shield newsletter covers the benefits, deadlines, and money mistakes that cost retirees, a couple times a week. Subscribe free.
What the shoe benefit actually includes
Each calendar year, Part B helps pay for therapeutic shoes and inserts for a qualifying beneficiary. A patient who cannot wear depth-inlay shoes because of a foot deformity can receive a pair of custom-molded shoes plus two additional pairs of inserts, while others qualify instead for a pair of extra-depth shoes and three pairs of inserts. In certain cases Medicare covers separate shoe modifications in place of inserts, giving the fitter room to adapt the benefit to the shape and condition of an individual patient’s foot.
The benefit arrives wrapped in a paperwork trail built specifically to prevent abuse. The physician managing the diabetes must certify the need, a podiatrist or other qualified doctor must actually prescribe the shoes, and the supplier furnishing them must be enrolled in Medicare. After the Part B deductible, the beneficiary pays 20 percent of the approved amount, and a supplier that is not participating and refuses assignment faces no ceiling at all on what it can charge above the Medicare rate, which can turn a modest benefit into a surprise.
That same certification chain explains why so many eligible patients never actually receive the shoes. The process requires two clinicians and an enrolled supplier to line up on the documentation, and a retiree who has never been told the coverage exists is unlikely to be the one to prompt that sequence into motion. The benefit sits fully available in the program’s rules, waiting on a diagnosis that has to be written down in exactly the right place before a single pair can be dispensed.
Why the benefit exists at all
The economics behind the rule are blunt and easy to follow. Diabetic foot ulcers and the amputations that can follow them rank among the most expensive complications Medicare pays for, and a properly fitted pair of therapeutic shoes is far cheaper than a hospitalization or the amputation and the long, costly recovery that trail it. By covering the shoes, the inserts, the twice-yearly exams, and the specialist visits, the program is deliberately spending small now in order to avoid spending very large later.
For a beneficiary newly diagnosed with neuropathy, the practical lesson is that none of this coverage activates on its own. A patient has to ask the treating physician to document the diagnosis and write the orders, then track down a supplier that is enrolled in Medicare, a multi-step sequence that many people simply never learn about until a foot problem has already started and the window for easy prevention has narrowed.
That leaves the coverage doing exactly what its design intends while still missing many of the patients who need it most. The benefit rewards those who happen to know to claim it and quietly passes over those who do not, which is why diabetes educators spend so much of their effort simply telling patients the shoes are there for the asking. Whether more amputations could be prevented if the benefit were routinely offered rather than merely available is a question the program’s own low uptake keeps posing.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
